Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region?
about
Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitisAntioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitisBile acids for non-alcoholic fatty liver disease and/or steatohepatitisDrugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitisThe global epidemiology of hepatocellular carcinoma: present and futureWhat are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?Simple scoring system for predicting cirrhosis in nonalcoholic fatty liver disease.Association between PPARGC1A polymorphisms and the occurrence of nonalcoholic fatty liver disease (NAFLD).Plasma Pentraxin3 is a novel marker for nonalcoholic steatohepatitis (NASH).Serum procalcitonin and CRP levels in non-alcoholic fatty liver disease: a case control study.In vivo lipid regulation mechanism of polygoni multiflori radix in high-fat diet fed ratsDietary saponins of sea cucumber alleviate orotic acid-induced fatty liver in rats via PPARalpha and SREBP-1c signalingNon-alcoholic Fatty Liver Disease Is a Risk Factor for Type 2 Diabetes in Middle-aged Japanese Men and Women.Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease.Expectations from imaging for pre-transplant evaluation of living donor liver transplantation.Interaction of obesity, metabolic syndrome and Framingham risk on steatohepatitis among healthy Taiwanese: population-based nested case-control study.Soluble CD14 levels reflect liver inflammation in patients with nonalcoholic steatohepatitis.Protective Role of Black Tea Extract against Nonalcoholic Steatohepatitis-Induced Skeletal DysfunctionCentrizonal arteries and microvessels in nonalcoholic steatohepatitis.Non-alcoholic fatty liver disease: The diagnosis and management.Hepatic steatosis in obese patients: clinical aspects and prognostic significance.Metabolic syndrome in South Asians.Probable NAFLD, by ALT levels, and diabetes among Filipino-American women.Effect of nonalcoholic Fatty liver disease on the development of type 2 diabetes in nonobese, nondiabetic korean men.Hyperuricemia Inversely Correlates with Disease Severity in Taiwanese Nonalcoholic Steatohepatitis Patients.Should nonalcoholic fatty liver disease be renamed?Severity of ultrasonographic liver steatosis and metabolic syndrome in Korean men and women.Modulation Effect of Peroxisome Proliferator-Activated Receptor Agonists on Lipid Droplet Proteins in Liver.An update on non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Asia.Pentraxin 3 Is a Predictor for Fibrosis and Arterial Stiffness in Patients with Nonalcoholic Fatty Liver Disease.Relationship between non-alcoholic fatty liver disease and inflammation in patients with non-alcoholic fatty liverPathology of fatty liver disease.Nonalcoholic steatohepatitis in nonalcoholic fatty liver disease patients of Bangladesh.The Prevalence of Metabolic Syndrome In Non-alcoholic Fatty Liver Disease; A Population-Based Study.The influence of waist circumference on insulin resistance and nonalcoholic fatty liver disease in apparently healthy Korean adults.Changing trends in gastrointestinal disease in the Asia-Pacific region.Normal serum aminotransferase levels and the metabolic syndrome: Korean National Health and Nutrition Examination Surveys.Advanced hepatic fibrosis and cirrhosis due to nonalcoholic fatty liver disease in Sri Lankan children: a preliminary reportProtective roles of adiponectin in obesity-related fatty liver diseases: mechanisms and therapeutic implications.Predictors for advanced fibrosis in morbidly obese non-alcoholic fatty liver patients.
P2860
Q24197984-853827AA-3A4F-4100-B2CB-5397FABB8511Q24243125-0B788144-0819-4FC2-AC72-9E1F9A5B0059Q24243149-66E356E7-00ED-4C24-8BB0-DB3BEBD8D752Q24246447-8AA4E9E4-5D55-454F-B157-3D0502DF2CE8Q28654353-A84A2EE4-1465-4F5C-8B2B-420019C22D1FQ30361645-A2484F50-1872-43CB-A2D0-7CBB65F9DEF1Q30433234-CC3CCB7A-C8CB-47D7-A22C-D57E472E8A91Q33347569-58478126-3B11-4F21-9CE9-C723D6F649ECQ33384921-BE1C76B5-0CD1-485C-8A0D-04CA0D120DB4Q33410004-C7505E4B-2397-467F-99DA-897BAA015859Q33615045-FC326E09-CC45-4496-854E-573A9A92EBBCQ33758991-B5C0D947-8BBF-4DC4-B5EC-CA15658913E8Q33760722-7A5E7105-A27A-418A-B249-7F0C25AC5C0DQ33777486-B0A35DB2-2105-4B53-B742-CF8FB62A60A3Q34251813-28CC49FE-51D9-4238-9036-5AF918FC295CQ34690842-C7A3BB78-D407-4428-B26B-E609311A3D58Q34769697-54C68A53-68B6-4228-94B4-4EA84E3109C5Q35101656-68038405-B9B8-449E-ADA1-17B1A67BAFAFQ35165370-A9510139-BA56-46CC-9250-2E963104B3C7Q35543956-344F1681-28A8-4A23-9389-391E222A186EQ35669794-9CDF7F4D-E69C-4158-B9EB-CBE359C7A5E3Q35686352-B3B324CE-F3F8-40F4-903C-94032D3B7CD6Q35882617-A0B1AC40-1736-4B28-A843-18AD86853E55Q36113307-4EB8F436-A132-498A-8D8D-D324B440A5D5Q36127895-4C5FC71C-37E8-4FF4-A7ED-FE648F6FDEECQ36141458-1544A763-FD02-4B56-971D-B1E613DD486FQ36213943-FD9C7D6B-AF23-452F-80F6-71E74461F174Q36386635-C1C38679-F002-42FE-8308-24D0B9349D6DQ36405031-94260B77-D87B-441D-BB90-1B76B342B2BCQ36656294-A5B30516-368C-4156-9C46-3EC03DF2FD51Q36671903-4650123E-3CD9-42B2-9AC0-7DD3228CEE9CQ36814311-35D33EFE-E3ED-4F9D-9A8F-53B32839B7DCQ36876388-24306796-D1CD-44AE-BC23-0A89138D6AF9Q36948009-B55A05D9-C9DA-4F2C-A5D4-9327D2B55AF2Q36983522-C3942F81-D16D-4617-842C-0B47383703FBQ36986006-F1ED2964-8679-4064-87AD-CCB4B8DFC1CBQ37205639-754B3308-51C8-455B-9740-3B8F13CA6C81Q37278127-6C51A3CE-D518-45E3-AB5C-6BC38800ECCCQ37494299-FCB16BA5-890E-4FF2-AA98-134D6C8930F1Q37590951-16AD4C34-0528-4071-905F-4EFA9C47ED9D
P2860
Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region?
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Non-alcoholic steatohepatitis: ...... nt in the Asia-Pacific region?
@ast
Non-alcoholic steatohepatitis: ...... nt in the Asia-Pacific region?
@en
type
label
Non-alcoholic steatohepatitis: ...... nt in the Asia-Pacific region?
@ast
Non-alcoholic steatohepatitis: ...... nt in the Asia-Pacific region?
@en
prefLabel
Non-alcoholic steatohepatitis: ...... nt in the Asia-Pacific region?
@ast
Non-alcoholic steatohepatitis: ...... nt in the Asia-Pacific region?
@en
P1476
Non-alcoholic steatohepatitis: ...... nt in the Asia-Pacific region?
@en
P2093
Geoffrey C Farrell
P2860
P304
P356
10.1046/J.1440-1746.2003.02989.X
P577
2003-02-01T00:00:00Z